longevitywatch

Can Magnetic Resonance Spectroscopy (MRS) detect Alzheimer's disease early?

Moderate evidence

MRS can signal brain abnormalities in early Alzheimer's disease, but is not yet ready for use as a standalone diagnostic tool. As a complement to PET scanning and other biomarkers the technique is promising, but larger standardised studies are needed before it offers practical benefit to patients.

NAA, a substance that reflects the health of nerve cells, is consistently reduced in the hippocampus and a specific part of the cerebral cortex (the posterior cingulate cortex) in people with early memory complaints as well as in people with Alzheimer's disease. Meta-analyses measure large effect sizes there: in the hippocampus, the difference compared with healthy individuals reaches a Hedges' g of -1.33, which in plain language means that the reduction is substantial and reproducibly measurable. This makes NAA the most consistent MRS marker to date.

Myo-inositol, a substance that rises during inflammation of the brain's support cells, increases in Alzheimer's disease and early memory complaints. What makes this interesting for early detection is that the increase is directly linked to the presence of amyloid-beta plaques in the brain, the characteristic protein deposits of Alzheimer's disease. Myo-inositol may therefore be able to signal abnormalities before nerve cells are actually lost. The NAA/myo-inositol ratio combines both signals and achieves high specificity in some studies for predicting who will go on to develop Alzheimer's disease. A small post-mortem study confirmed that this ratio is also associated with loss of connections between nerve cells and accumulation of tau protein.

Other brain substances that MRS can measure, such as choline, glutamate and GABA, show a mixed picture. Results contradict each other too often to be reliable at this stage, partly because measurement protocols differ considerably between research centres. One meta-analysis found reduced glutathione levels (an antioxidant) in people with early memory complaints, possibly a sign of oxidative stress, but this has been studied too little to draw any conclusions from it.

The practical bottleneck is that MRS on its own is not specific enough for a definitive Alzheimer's diagnosis. Reviews emphasise that the absence of uniform measurement standards and large long-term studies is blocking the move into clinical practice. The technique holds the most promise as a complement to other investigations, such as a PET scan. Such a combination could help identify for whom further investigation is worthwhile, but this has not yet been validated on a large scale.

The evidence
8 studies · 3 meta-analyses

Evidence based on three meta-analyses/systematic reviews (PMID 26402632, 23969177, 34751136), multiple reviews (PMID 15853510, 16162090, 18445744) and two other studies (PMID 38427192, 25471565). Associational in nature; no RCTs. No claims are made regarding clinical effectiveness as a validated diagnostic instrument.

Last checked: October 2026 · how this was judged
Related answers

Does Alzheimer's begin decades before diagnosis?

Yes, the biological changes in Alzheimer's disease begin on average roughly twenty years before diagnosis, but symptoms appear much later. Early detection through blood tests is becoming increasingly feasible, although it remains unclear whether early intervention can genuinely halt the disease.

How effective are cholinesterase inhibitors in Alzheimer's disease?

These drugs show a measurable slowing of mental decline in Alzheimer's disease, although the effect is modest. Galantamine and donepezil have the strongest evidence base; discuss the options with a neurologist or treating physician.

Can I test my Alzheimer's risk with a blood test (p-tau217)?

A p-tau217 blood test gives a reliable first impression of amyloid build-up in the brain, an early hallmark of Alzheimer's disease. The test is most useful if you already have cognitive symptoms; discuss it with your doctor.

Yes · Strong evidence

How quickly does the risk of Alzheimer's disease increase as you get older?

The risk of Alzheimer's disease clearly increases with age, but the risk within each age group has remained stable over recent decades. An ageing population is driving the growing number of cases worldwide, which makes factors you can influence all the more relevant.

Is there a link between oral bacteria and the development of Alzheimer's disease?

There is a consistent association between oral bacteria and Alzheimer's disease, but a proven cause-and-effect relationship in humans has not yet been established. Good oral care is sensible, but do not expect it to offer proven protection against Alzheimer's disease.

Does poor sleep cause dementia sooner?

Poor sleep probably increases your risk of dementia, but ordinary insomnia does not make dementia inevitable. One exception: if you physically act out your dreams while sleeping, discuss that with a doctor.

Yes · Moderate evidence
Related research
21 Nov
Reading linked to 33% lower Alzheimer’s risk
21 Nov
Boosting one protein slows brain aging and keeps memory sharp in mice
20 Nov
Brain protein shields neurons from Alzheimer’s damage in mice
Don't see your question?
Ask it and we'll look it up for you.
Ask a question →
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.